EditorialKommentar
An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients
NEJM Evidence · 2024
DOI: 10.1056/evide2400022 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, 2024. Verfasst von LaQuisa C Hill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston. Hauptthemen laut MEDLINE: Ethnic and Racial Minorities, Immunotherapy, Adoptive. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Ethnic and Racial MinoritiesImmunotherapy, AdoptiveHumansEthnicityReceptors, Chimeric AntigenMinority GroupsFemaleMale
Substanzen
Receptors, Chimeric Antigen
Autor:innen und Institutionen
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston.
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA.
- Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.
Zitieren
APA
Hill, L. C., & Smith, M. (2024). An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients. NEJM Evidence. https://doi.org/10.1056/evide2400022
Vancouver
Hill LC, Smith M. An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients. NEJM Evidence. 2024. doi:10.1056/evide2400022
BibTeX
@article{Hill2024,
author = {Hill, LaQuisa C and Smith, Melody},
title = {An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients},
journal = {NEJM Evidence},
year = {2024},
doi = {10.1056/evide2400022}
}
EUVIMED